mhurhangee/ep-ind-claims huggingface dataset:
A tire comprising: a pair of beads having a bead core and a bead filler extending to an outer side in a tire-radial direction of the bead core; a carcass ply extending from one bead to another bead; an inner liner disposed at a tire inner cavity side of the carcass ply; and an electronic component unit pasted to a tire inner cavity side of the inner liner, wherein the electronic component unit is disposed at a tire-radial direction position distanced at least 5.0 mm to an outer side in the tire-radial direction from a tire-radial direction outside end of the bead core, characterized in that when drawing a normal line from the tire inner cavity side of the inner liner in a tire-width direction cross-sectional view, and defining a portion at which a distance from the tire inner cavity side of the inner liner to the tire outer surface becomes longest as a bead thickest part, wherein the electronic component unit is disposed an inner side in the tire-radial direction than a position of the tire inner cavity side of the inner liner configuring the bead thickest part. a pair of beads having a bead core and a bead filler extending to an outer side in a tire-radial direction of the bead core; a carcass ply extending from one bead to another bead; an inner liner disposed at a tire inner cavity side of the carcass ply; and an electronic component unit pasted to a tire inner cavity side of the inner liner, wherein the electronic component unit is disposed at a tire-radial direction position distanced at least 5.0 mm to an outer side in the tire-radial direction from a tire-radial direction outside end of the bead core, characterized in that when drawing a normal line from the tire inner cavity side of the inner liner in a tire-width direction cross-sectional view, and defining a portion at which a distance from the tire inner cavity side of the inner liner to the tire outer surface becomes longest as a bead thickest part, wherein the electronic component unit is disposed an inner side in the tire-radial direction than a position of the tire inner cavity side of the inner liner configuring the bead thickest part.
A shielding assembly for an infusion system, the shielding assembly comprising a plurality of compartments and providing a radioactive radiation barrier for the compartments, the assembly further comprising: a first door to alternately enclose and provide access to a first compartment of the plurality of compartments, the first compartment sized to contain one or more radioisotope generators of the infusion system; and a second door to alternately enclose and provide access to a second compartment of the plurality of compartments, the second compartment being separate from, and outside of, the first compartment, the second compartment being sized to contain a portion of an infusion tubing circuit of the infusion system that is downstream of the one or more generators, and the second door, when enclosing the second compartment, preventing the first door from opening to provide access to the first compartment, characterised in that the first door defines a first door edge; the second door defines a second door edge; and the second door edge overlaps the first door edge so as to prevent the first door from being opened if the second door is not open. a first door to alternately enclose and provide access to a first compartment of the plurality of compartments, the first compartment sized to contain one or more radioisotope generators of the infusion system; and a second door to alternately enclose and provide access to a second compartment of the plurality of compartments, the second compartment being separate from, and outside of, the first compartment, the second compartment being sized to contain a portion of an infusion tubing circuit of the infusion system that is downstream of the one or more generators, and the second door, when enclosing the second compartment, preventing the first door from opening to provide access to the first compartment, characterised in that the first door defines a first door edge; the second door defines a second door edge; and the second door edge overlaps the first door edge so as to prevent the first door from being opened if the second door is not open.
A cooling circuit for a motor vehicle comprising a first cooling loop designed to ensure the thermoregulation of a first member and at least one second cooling loop designed to ensure the thermoregulation of a second member, each cooling loop (I, II, III) designed to ensure the thermoregulation of a member being fluidly connected to a unique degassing box, characterized in that each cooling loop (I, II, III) designed to ensure the thermoregulation of a member comprises a degassing module provided with a hydrophobic porous element, comprising a porous diaphragm superimposed on a pre-filter medium, through which air bubbles, contained in said cooling loop (I, II, III) escape to join the degassing box.
A method of identifying a subject having non-Hodgkin's lymphoma that is responsive to treatment with an anti-CD19 antibody, said method comprising: a. providing a blood sample obtained from said subject prior to treatment with said anti-CD19 antibody, b. determining the level of at least one biomarker in said sample selected from the group consisting of: i. peripheral NK cell count, and ii. CD16 expression levels on peripheral NK cells, c. comparing the level of said at least one biomarker in said sample to a predetermined cut off level, wherein levels of said at least one biomarker at or above the predetermined cut off level is indicative of a subject who would benefit from treatment with an anti-CD19 antibody. a. providing a blood sample obtained from said subject prior to treatment with said anti-CD19 antibody, b. determining the level of at least one biomarker in said sample selected from the group consisting of: i. peripheral NK cell count, and ii. CD16 expression levels on peripheral NK cells, i. peripheral NK cell count, and ii. CD16 expression levels on peripheral NK cells, c. comparing the level of said at least one biomarker in said sample to a predetermined cut off level, wherein levels of said at least one biomarker at or above the predetermined cut off level is indicative of a subject who would benefit from treatment with an anti-CD19 antibody.
A concealable film comprising 10 to 94% by mass of a crystalline polyamide resin, 1 to 40% by mass of an amorphous polyamide resin and 5 to 50% by mass of titanium oxide, with the proviso that the total content of these is 100% by mass.
A method for treating through oxidation waste containing an organic material and nitrates in a reaction medium comprising water in the supercritical state at a pressure higher than 221 bar and a temperature higher than 374°C in a reactor comprising a body delimiting a reaction zone, an inlet for the material to be treated in the reaction zone, an introduction point for an oxidant in the reaction zone, at least one outlet for the material treated outside the reaction zone, the material to be treated travelling a defined path in the reaction zone between its inlet and its outlet, the introduction point for the oxidant into the reaction zone being located downstream of the inlet of the material and is spaced apart from the same by some distance so as to define an anoxia zone between the inlet of the material to be treated and the introduction point for the oxidant, in which zone the fluid medium is in anoxia, the reactor comprising an inner tube connected to the body at a first end, the internal volume of the inner tube delimiting a central zone, the inner tube delimiting an annular zone with the body, a communication passage between the central zone of the tube and the annular zone being provided at a second end of the inner tube, the inlet of the material to be treated opening into the central zone of the inner tube, on its first end side, the introduction point for the oxidant being located in the vicinity of the second end of the inner tube, the oxidation zone being located downstream of the anoxia zone in the annular zone, the treating method comprising the following steps of: - introducing a material to be treated into the reaction zone through the inlet of the material; - introducing an oxidant into the reaction zone through the introduction point, oxidising the organic material by the nitrates which are reduced by being converted into nitrogen under supercritical hydrothermal oxidation conditions in the anoxia zone, the oxidation of the waste being completed in the oxidation zone downstream of the anoxia zone and of the oxidant inlet. - introducing a material to be treated into the reaction zone through the inlet of the material; - introducing an oxidant into the reaction zone through the introduction point, oxidising the organic material by the nitrates which are reduced by being converted into nitrogen under supercritical hydrothermal oxidation conditions in the anoxia zone, the oxidation of the waste being completed in the oxidation zone downstream of the anoxia zone and of the oxidant inlet.
A method for monitoring locking means (4, 6, 7) of a thrust reversing electrical system for an aircraft turbomachine, said electrical system having a thrust reverser and a first, a second and a third locking means, the locking means (4, 6, 7) being able to be placed in a closed position in which extending the thrust reverser is not possible, and in an open position in which extending the thrust reverser is possible, opening and closing the first and second locking means (6, 7) being controlled by a control box, the control box and the third locking mean being powered by an aircraft electrical network, characterised in that the method is carried out by a computer before the plane take-off, and comprises the following steps: • a step of sending a command for opening the locking means (4, 6, 7), comprising the following sub-steps: o sending to the aircraft electrical network an order for energizing the control box and the third locking mean; o sending to the control box an order for opening the first and second locking means (6, 7); • checking the opening of said locking means; • sending a command for closing the locking means. • a step of sending a command for opening the locking means (4, 6, 7), comprising the following sub-steps: o sending to the aircraft electrical network an order for energizing the control box and the third locking mean; o sending to the control box an order for opening the first and second locking means (6, 7); o sending to the aircraft electrical network an order for energizing the control box and the third locking mean; o sending to the control box an order for opening the first and second locking means (6, 7); • checking the opening of said locking means; • sending a command for closing the locking means.
A process for making cyclopentadiene and/or dicyclopentadiene (DCPD), the process comprising: feeding a C5 feedstock comprising at least one acyclic C5 hydrocarbon and a light hydrocarbon co-feedstock comprising at least one C1 to C4 hydrocarbon into a first reactor; contacting the at least one acyclic C5 hydrocarbon with a catalyst under conversion conditions to obtain a first reactor hydrocarbon effluent from an outlet on the first reactor comprising: C5 components including CPD and acyclic diolefins; light components including hydrogen and C1-C4 hydrocarbons; one-ring aromatics; and multiple-ring aromatics; wherein sufficient light hydrocarbon co-feedstock is provided in step such that: the total absolute pressure of the first reactor hydrocarbon effluent at the outlet is P(fre); the total partial pressure of C5 hydrocarbons in the first reactor hydrocarbon effluent at the outlet is P; the partial pressure of hydrogen in the first reactor hydrocarbon effluent at the outlet is P; where [P + P] ÷ P(fre) ≤ 0.90; and P(fre) is greater than 100 kilopascal absolute; and wherein dicyclopentadiene is obtainable from cyclopentadiene via Diels-Alder condensation. feeding a C5 feedstock comprising at least one acyclic C5 hydrocarbon and a light hydrocarbon co-feedstock comprising at least one C1 to C4 hydrocarbon into a first reactor; contacting the at least one acyclic C5 hydrocarbon with a catalyst under conversion conditions to obtain a first reactor hydrocarbon effluent from an outlet on the first reactor comprising: C5 components including CPD and acyclic diolefins; light components including hydrogen and C1-C4 hydrocarbons; one-ring aromatics; and multiple-ring aromatics; wherein sufficient light hydrocarbon co-feedstock is provided in step such that: the total absolute pressure of the first reactor hydrocarbon effluent at the outlet is P(fre); the total partial pressure of C5 hydrocarbons in the first reactor hydrocarbon effluent at the outlet is P; the partial pressure of hydrogen in the first reactor hydrocarbon effluent at the outlet is P; where [P + P] ÷ P(fre) ≤ 0.90; and P(fre) is greater than 100 kilopascal absolute; and wherein dicyclopentadiene is obtainable from cyclopentadiene via Diels-Alder condensation.
An authentication system including a first device that connects to a first controller by a first network and to a second controller by a second network, and a second device that connects to the second controller by the second network, wherein, upon the first device receiving a certificate revocation list from the first controller, the first device detects that the second device is connected to the second controller to which also the first device is connected, said authentication system being characterised by the first device further transmits the certificate revocation list to the second device if the storage capacity of the second device is smaller than a predetermined threshold value, and also a certificate identifier of a public key certificate is listed in the certificate revocation list, and does not transmit the certificate revocation list to the second device if the storage capacity of the second device is smaller than a predetermined threshold value, and also if the certificate identifier is not listed in the certificate revocation list. detects that the second device is connected to the second controller to which also the first device is connected, said authentication system being characterised by the first device further transmits the certificate revocation list to the second device if the storage capacity of the second device is smaller than a predetermined threshold value, and also a certificate identifier of a public key certificate is listed in the certificate revocation list, and does not transmit the certificate revocation list to the second device if the storage capacity of the second device is smaller than a predetermined threshold value, and also if the certificate identifier is not listed in the certificate revocation list.
A composite implant comprising: a bioerodible cross-linked polyethylene glycol hydrogel; and a therapeutic complex comprising: a therapeutic agent, wherein the therapeutic agent is selected from at least one of a protein or a peptide; and mesoporous silica particles; wherein the therapeutic complex is dispersed in the bioerodible cross-linked polyethylene glycol hydrogel. a bioerodible cross-linked polyethylene glycol hydrogel; and a therapeutic complex comprising: a therapeutic agent, wherein the therapeutic agent is selected from at least one of a protein or a peptide; and mesoporous silica particles; wherein the therapeutic complex is dispersed in the bioerodible cross-linked polyethylene glycol hydrogel. a therapeutic agent, wherein the therapeutic agent is selected from at least one of a protein or a peptide; and mesoporous silica particles; wherein the therapeutic complex is dispersed in the bioerodible cross-linked polyethylene glycol hydrogel.
A method for producing a sheet for a sealing member of a solar cell, the method comprising (a) preparing a thermal adhesive resin containing an olefinic resin as a main component, (b) pulverizing the thermal adhesive resin into a powder and spreading the powder, and (c) heating the thermal adhesive resin powder to a temperature not hig her than the melting point of the resin powder to produce a sheet comprising a plurali ty of pores, wherein the olefinic resin comprises an ethylene resin, and wherein the et hylene resin contains 60% to 90% by weight of ethylene, said thermal adhesive resin having a melt mass-flow rate of 1 g/10 min to 50 g/10 min, as measured in accordance with JIS K6924-1. (a) preparing a thermal adhesive resin containing an olefinic resin as a main component, (b) pulverizing the thermal adhesive resin into a powder and spreading the powder, and (c) heating the thermal adhesive resin powder to a temperature not hig her than the melting point of the resin powder to produce a sheet comprising a plurali ty of pores, wherein the olefinic resin comprises an ethylene resin, and wherein the et hylene resin contains 60% to 90% by weight of ethylene, said thermal adhesive resin having a melt mass-flow rate of 1 g/10 min to 50 g/10 min, as measured in accordance with JIS K6924-1.
A cosmetic composition suitable for lightening regions of mammalian skin, comprising: an effective amount of Ficus Serum Fraction derived from fresh Ficus leaf juice; and a dermatologically acceptable carrier, wherein said Ficus Serum Fraction is produced by the process comprising: a. separating ficus cell juice from clean, fresh, un-wilted ficus leaves to obtain fresh ficus cell juice, wherein no exogenous liquid is added prior or during said separating: b. filtering said fresh ficus cell juice to obtain fiber-free cell juice; c. fractionating said fiber-free cell juice to obtain Ficus Serum Fraction, wherein said fractionating comprises: removing chlorophyll from said fiber-free cell juice to obtain Supernatant I; removing pigments and proteins from Supernatant I to form Ficus Serum Fraction; adding stabilizer to said Ficus Serum Fraction. an effective amount of Ficus Serum Fraction derived from fresh Ficus leaf juice; and a dermatologically acceptable carrier, a. separating ficus cell juice from clean, fresh, un-wilted ficus leaves to obtain fresh ficus cell juice, wherein no exogenous liquid is added prior or during said separating: b. filtering said fresh ficus cell juice to obtain fiber-free cell juice; c. fractionating said fiber-free cell juice to obtain Ficus Serum Fraction, wherein said fractionating comprises: removing chlorophyll from said fiber-free cell juice to obtain Supernatant I; removing pigments and proteins from Supernatant I to form Ficus Serum Fraction; adding stabilizer to said Ficus Serum Fraction. removing chlorophyll from said fiber-free cell juice to obtain Supernatant I; removing pigments and proteins from Supernatant I to form Ficus Serum Fraction; adding stabilizer to said Ficus Serum Fraction.
A process, comprising: forming at least one precursor abrasive component (201; 301) on a core (202; 302; 502), the precursor abrasive component (201; 301) including a body (210; 310) having a metal bond matrix and abrasive particles contained within the metal bond matrix; and infiltrating at least a portion of the body (210; 310) after forming, characterized in that, forming the precursor abrasive component (201; 301) on the core (202; 302; 502) comprises simultaneous formation of the body (210; 310) and joining of the precursor abrasive component (201; 301) to the core (210; 310). forming at least one precursor abrasive component (201; 301) on a core (202; 302; 502), the precursor abrasive component (201; 301) including a body (210; 310) having a metal bond matrix and abrasive particles contained within the metal bond matrix; and infiltrating at least a portion of the body (210; 310) after forming, characterized in that, forming the precursor abrasive component (201; 301) on the core (202; 302; 502) comprises simultaneous formation of the body (210; 310) and joining of the precursor abrasive component (201; 301) to the core (210; 310).
A device for deployment within a human heart, comprising: an anchor (70, 100) having a delivery configuration and a deployed configuration, the anchor (70, 100) comprising a distal end and a proximal end and having a main body member, the anchor (70, 100) further comprising a plurality of radially-expandable prongs extending from the main body member, wherein the radially-expandable prongs include tips, wherein, with the anchor (70, 100) in the delivery configuration, the plurality of radially-expandable prongs extend generally distally from the main body member, and wherein, with the anchor (70, 100) in the deployed configuration, the plurality of radially expandable prongs extend generally radially from the main body; and an elongate member having a first end and a second end, wherein the elongate member first end is secured to the proximal end of the anchor (70, 100), and the elongate member second end is configured to be secured to heart tissue, characterized in that the elongate member is releasably secured to the proximal end of the anchor (70, 100). an anchor (70, 100) having a delivery configuration and a deployed configuration, the anchor (70, 100) comprising a distal end and a proximal end and having a main body member, the anchor (70, 100) further comprising a plurality of radially-expandable prongs extending from the main body member, wherein the radially-expandable prongs include tips, wherein, with the anchor (70, 100) in the delivery configuration, the plurality of radially-expandable prongs extend generally distally from the main body member, and wherein, with the anchor (70, 100) in the deployed configuration, the plurality of radially expandable prongs extend generally radially from the main body; and an elongate member having a first end and a second end, wherein the elongate member first end is secured to the proximal end of the anchor (70, 100), and the elongate member second end is configured to be secured to heart tissue, characterized in that the elongate member is releasably secured to the proximal end of the anchor (70, 100).